by Lorena Bindszus | May 7, 2025 | News
We are grateful for our team’s dedication and this significant achievement. ABX-CRO is proud to announce the successful completion of an FDA pre-approval inspection for a PET radiodiagnostic with a biological pharmacophore of a global phase III trial conducted by...
by FBorchert | Feb 10, 2025 | News
ABX-CRO wholeheartedly congratulates ITM (Isotope Technologies Munich) to the successful outcome of the COMPETE study (ITM-11 (n.c.a. 177Lu-DOTATOC) in GEP-NET) The success of COMPETE, marks another milestone in ABX-CRO´s unique track record designing and conducting...
by FBorchert | Jan 17, 2025 | News
The scientific and commercial members of the globally unique radiopharmaceutical competence cluster Dresden/Radeberg (Saxony, Germany), comprehensively covering the entire radiopharmaceutical value creation chain from targetry, discovery over R & D, manufacturing,...
by FBorchert | Jan 13, 2025 | News
In 2025 we would like to take the opportunity to welcome our new employee in India: Dr. Rakhee Vatsa! She has started at ABX-CRO India in September 2024 as Technical Head CDMO. Since then she has been awarded the Distinguished Alumnus Award on Dec 21, 2024 by the...
by FBorchert | Oct 2, 2024 | News
We are extremely proud that our central involvement in designing, execution and analysis of of the Telix ZIRCON pivotal phase III study was recently recognised in The Lancet Group Oncology. This prospective, open-label, multicentre study evaluated the clinical utility...
by FBorchert | Jun 21, 2024 | News
This summer we welcome our first two trainees. We look forward to seeing them learn and...
